Results 91 to 100 of about 138,341 (212)

Indolent lymphoma: the pathologist's viewpoint [PDF]

open access: yes, 2017
Indolent lymphomas have recently been the object of numerous studies, which have focused on new aspects relevant both for the better comprehension of their histogenesis and the identification of new therapeutic strategies. As marginal-zone lymphoma (MZL)
Bendandi, M.   +4 more
core  

The pro-differentiating capability of a flavonoid-rich extract of Citrus bergamia juice prompts autophagic death in THP-1 cells

open access: yesScientific Reports
Acute myeloid leukemia (AML) is a hematologic neoplasm, characterized by a blockage of differentiation and an unconstrained proliferation of immature myeloid cells.
Laura Musumeci   +5 more
doaj   +1 more source

Full Issue: Volume 13, Issue 1 - Winter 2018 [PDF]

open access: yes, 2018
Full Issue: Volume 13, Issue 1 - Winter ...

core   +1 more source

UMBILICO-PLACENTAL ANTIGENS AND MALIGNANT NEOPLASMS

open access: yesUMBILICO-PLACENTAL ANTIGENS AND MALIGNANT NEOPLASMS
Serological reactions between anti-human placental tissue antiserum and 584 human sera from patients of various diseases and conditions have been tested using the micro-Ouchterlony method. Relatively high incidence of positive reaction was noted with cases of malignant tumours (57.5%), leukaemia (63.6%), pregnancy (77.8%), myocardial infarction (41.2%),
openaire  

Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies [PDF]

open access: yes, 2010
Derfuss, Tobias   +4 more
core   +1 more source

Erythema Gyratum Repens Without an Associated Neoplasm: A Rheumatoid Twist. [PDF]

open access: yesCureus
Joseph Bella J   +4 more
europepmc   +1 more source

Recent developments in cancer immuno-interception strategies. [PDF]

open access: yesTrends Mol Med
Zhu Z   +7 more
europepmc   +1 more source

Endogenous immune recruitment in glioblastoma CAR T therapy: cytokine, myeloid, and chemokine circuitry. [PDF]

open access: yesJ Neurooncol
Liu J   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy